Many Medicare beneficiaries are at risk for financial hardship from the costs of a single hospital stay, according to a study.

Among privately insured patients, there was a doubling in the use of GLP-1 RAs as antiobesity treatment from 2022 to 2023, with a simultaneous 25.6% decrease in the rate of metabolic bariatric surgery ...

Patients in rural counties had higher rates of mortality and were readmitted more frequently following COVID-19 hospitalization over the long term.

Cell-free DNA blood tests (cf-bDNA) may be more costly and less effective for colorectal cancer (CRC) screening than other screening modalities.

Access to health care among patients with IBD includes barriers like financial struggles and challenges in access to treatment.

Clinicians fail to rescue female patients with complications after high-risk vascular and cardiac surgeries more often than male patients.

The approved of Vistaseal has been expanded to include use in pediatric patients as an adjunct to hemostasis for mild to moderate bleeding.

The use of SGLT2 inhibitors vs sulfonylurea was associated with a reduced risk for incident gout and MACE among patients with type 2 diabetes with/at risk for gout.

Telemedicine increases access to hepatitis C virus treatment, especially among individuals in underserved communities.

Roxybond (oxycodone hydrochloride) immediate-release 10mg tablet for the management of pain severe enough to require an opioid analgesic.

The US FDA has approved Vyloy in combination with fluoropyrimidine- and platinum-containing chemotherapy for the first-line treatment of advanced gastric or gastroesophageal junction cancer.

The prevalence of HCV among men who have sex with men with non-injection drug use is linked to age and drug use patterns.